OSLER DIAGNOSTICS LIMITED

Active Oxford

Research and experimental development on biotechnology

153 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

OSLER DIAGNOSTICS LIMITED

Research and experimental development on biotechnology

Founded 11 Feb 2016 Active Oxford, England 153 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

OXFORD IMPEDANCE DIAGNOSTICS LIMITED 11 Feb 2016 — 5 Sept 2017
Accounts Submitted 19 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 12 Feb 2026 Next due 24 Feb 2027 10 months remaining
Net assets £37M £23M 2024 year on year
Total assets £41M £23M 2024 year on year
Total Liabilities £3M £176K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

King Charles House Park End Street Oxford OX1 1JD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for OSLER DIAGNOSTICS LIMITED (10001467), an active life sciences and medical technology company based in Oxford, England. Incorporated 11 Feb 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£27.99M

Decreased by £23.24M (-45%)

Net Assets

£37.47M

Decreased by £23.02M (-38%)

Total Liabilities

£3.40M

Increased by £176.00k (+5%)

Turnover

N/A

Employees

153

Increased by 23 (+18%)

Debt Ratio

8%

Increased by 3 (+60%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 4

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 5Jun 2016Seed
Investor 6Jun 2016Seed
Investor 7Jun 2016Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 487,147 Shares £110.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Feb 202316,867£4.44m£263.25
8 Nov 2022269,881£71.05m£263.25
19 Jan 20215,734£1.00m£174.4
20 Nov 2020194,665£33.95m£174.4

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (55)

Oxford Science Enterprises Holdings Ii Limited
18.6%
203,707
Werfen S.a
10.8%
118,075

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Notified 31 Mar 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Ceased

Group Structure

Group Structure

OSLER DIAGNOSTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Feb 2026Confirmation StatementConfirmation statement made on 2026-02-10 with updates
31 Jan 2026OfficersChange to director Mr Andre Crawford-Brunt on 2026-01-29
22 Jan 2026OfficersAppointment of John Joseph Sperzel Iii as director on 2026-01-21
19 Sept 2025AccountsAnnual accounts made up to 2024-12-31
5 Jun 2025Persons With Significant ControlCessation of Oxford Science Enterprises Plc as a person with significant control on 2025-03-31
12 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-02-10 with updates

31 Jan 2026 Officers

Change to director Mr Andre Crawford-Brunt on 2026-01-29

22 Jan 2026 Officers

Appointment of John Joseph Sperzel Iii as director on 2026-01-21

19 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

5 Jun 2025 Persons With Significant Control

Cessation of Oxford Science Enterprises Plc as a person with significant control on 2025-03-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-02-10 with updates

2 months ago on 12 Feb 2026

Change to director Mr Andre Crawford-Brunt on 2026-01-29

2 months ago on 31 Jan 2026

Appointment of John Joseph Sperzel Iii as director on 2026-01-21

2 months ago on 22 Jan 2026

Annual accounts made up to 2024-12-31

7 months ago on 19 Sept 2025

Cessation of Oxford Science Enterprises Plc as a person with significant control on 2025-03-31

10 months ago on 5 Jun 2025